FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: As the nation's capital, the District of Columbia is home to numerous federal employees and residents who would be directly impacted by the availability of a new flu vaccine. The Executive Office of the Mayor and local health agencies will likely review guidelines and prepare for potential distribution should the FDA grant approval.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.